In 2017, a Children’s Hospital Los Angeles team led by Jesse Berry, MD, pioneered the development of the first liquid biopsy for retinoblastoma, the most common childhood eye cancer. But while the biopsy information–taken from the aqueous humor fluid in the front of the eye–could be studied in the lab, it wasn’t yet able to be applied to patient care.
